Core Technology

Cellid Co.,Ltd. leads development of anti-cancer immunotherapy.

Original CeliVax Technology

Antigen Presenting Cells

Antigen Presenting Cells (APC) are cells that present foreign antigens such as tumor cells and virus to immune cells to induce immune responses.
CeliVax uses B cells and monocytes as APCs.

B cells/monocytes

  • Cellid developed the world’s first technology of utilizing B cells and monocytes as high-efficiency APC.
  • A sufficient amount of B cells and monocytes can be easily collected from peripheral blood, which makes the drug manufacturing process fast and robust.
  • With an appropriate adjuvant, B cells and monocytes can stimulate T cell activation as efficiently as dendritic cells.